paclitaxel has been researched along with Bile Duct Obstruction in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, SI; Jeong, S; Kim, MH; Lee, DH; Lee, DK; Lee, SJ; Yoon, HJ | 1 |
| Bahra, M; Denecke, T; Jühling, A; Klein, F; Pelzer, U; Riess, H; Roemmler-Zehrer, J; Sinn, M; Striefler, J; Wislocka, L | 1 |
| Cao, J; Cui, W; Wang, X; Yuan, T; Zhu, Y | 1 |
| Choi, JS; Jang, SI; Jeong, S; Kim, YT; Lee, DH; Lee, DK; Lee, KT; Lee, SH; Yu, JS | 1 |
| Jang, SI; Jeong, S; Lee, DH; Lee, DK; Na, K; Yang, S | 1 |
| Fan, C; Geng, Z; Lv, Y; Shi, J; Yu, L; Zhang, B; Zhang, X | 1 |
| Beckebaum, S; Cicinnati, VR; Hüsing, A; Kabar, I; Reinecke, H; Schmidt, HH; Wilms, C | 1 |
| Fuji, H; Furumoto, K; Ito, D; Kogire, M; Kojima, H; Mori, T; Nagashima, D; Okuno, M | 1 |
| Beckebaum, S; Cicinnati, VR; Cordesmeyer, S; Kabar, I; Reinecke, H; Schmidt, HH | 1 |
| Emoto, S; Hirano, K; Isayama, H; Ishigami, H; Kawakubo, K; Kitayama, J; Kogure, H; Koike, K; Nakai, Y; Sasahira, N; Sasaki, T; Tada, M; Yamaguchi, H; Yamamoto, N | 1 |
| Han, J; Jang, SI; Kim, HG; Kim, JH; Lee, DK; Lee, SJ; Park, SH; Rhee, K; Shin, IH; You, JW | 1 |
| Avsar, Y; Beckebaum, S; Cicinnati, VR; Cordesmeyer, S; Kabar, I; Reinecke, H; Schmidt, HH | 1 |
| Shah, T | 1 |
| Baik, SK; Kim, HG; Kim, HS; Kim, JW; Lee, DH; Lee, DK; Lee, SJ; Oh, SJ; Suk, KT; Won, YH | 1 |
| Goodin, S; Gosland, M; Hoffman, T; Tsuboi, C; Vore, M | 1 |
| Gosland, M; Hoffman, T; Huang, L; Liu, Y; Vore, M | 1 |
| Hoffman, T; Huang, L; Vore, M | 1 |
1 review(s) available for paclitaxel and Bile Duct Obstruction
| Article | Year |
|---|---|
Efficacy and safety evaluation of paclitaxel-loaded metal stents in patients with malignant biliary obstructions.
Topics: Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cholestasis; Drug-Eluting Stents; Humans; Metals; Paclitaxel; Treatment Outcome | 2019 |
3 trial(s) available for paclitaxel and Bile Duct Obstruction
| Article | Year |
|---|---|
Efficacy of a Multiplex Paclitaxel Emission Stent Using a Pluronic
Topics: Aged; Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cholestasis; Drug-Eluting Stents; Early Termination of Clinical Trials; Female; Humans; Male; Metals; Middle Aged; Paclitaxel; Poloxamer; Prospective Studies; Surface-Active Agents; Treatment Outcome | 2017 |
Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Phytogenic; Cholestasis; Decanoic Acids; Digestive System Neoplasms; Drug-Eluting Stents; Humans; Middle Aged; Paclitaxel; Prospective Studies | 2019 |
Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cholestasis; Drug-Eluting Stents; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Paclitaxel | 2013 |
14 other study(ies) available for paclitaxel and Bile Duct Obstruction
| Article | Year |
|---|---|
[French comment on article Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study].
Topics: Cholestasis; Decanoic Acids; Humans; Metals; Paclitaxel; Prospective Studies; Stents | 2019 |
Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Databases, Factual; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Hyperbilirubinemia; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Cholestasis; Common Bile Duct; Decanoic Acids; Drug-Eluting Stents; Neoplasms; Paclitaxel; Self Expandable Metallic Stents; Serum Albumin; Sus scrofa; Swine | 2019 |
Interest of a new biodegradable stent coated with paclitaxel on anastomotic wound healing after biliary reconstruction.
Topics: Absorbable Implants; Anastomosis, Surgical; Animals; Cholestasis; Coated Materials, Biocompatible; Common Bile Duct; Dogs; Drug Administration Schedule; Drug-Eluting Stents; Equipment Design; Jejunum; Paclitaxel; Polyesters; Tubulin Modulators; Wound Healing | 2013 |
Paclitaxel-eluting balloon dilation of biliary anastomotic stricture after liver transplantation.
Topics: Adult; Catheters; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Coated Materials, Biocompatible; Constriction, Pathologic; Equipment Design; Feasibility Studies; Female; Germany; Hospitals, University; Humans; Liver Transplantation; Male; Middle Aged; Paclitaxel; Pilot Projects; Prospective Studies; Recurrence; Time Factors; Treatment Outcome | 2015 |
[Improved QOL in a case of remnant gastric cancer with common bile duct obstruction treated with weekly paclitaxel therapy and cholecystojejunostomy].
Topics: Aged; Antineoplastic Agents, Phytogenic; Cholecystostomy; Cholestasis; Humans; Jejunostomy; Male; Paclitaxel; Quality of Life; Salvage Therapy; Stomach Neoplasms | 2012 |
Introducing paclitaxel-eluting balloons as a new treatment option of biliary-enteric anastomotic stricture after liver transplantation.
Topics: Adult; Anastomosis, Surgical; Catheterization; Cholestasis; Female; Humans; Liver Transplantation; Paclitaxel | 2012 |
Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Drainage; Drug Combinations; Endoscopy, Digestive System; Female; Humans; Intestinal Obstruction; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stents; Stomach Neoplasms; Tegafur | 2012 |
Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantation.
Topics: Adult; Anastomosis, Surgical; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Cohort Studies; Constriction, Pathologic; Dilatation; Female; Germany; Humans; Liver Transplantation; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prognosis; Prospective Studies; Risk Assessment; Stents; Treatment Outcome | 2012 |
Drug-eluting stents in malignant biliary obstruction: where do we stand?
Topics: Antineoplastic Agents, Phytogenic; Cholestasis; Drug-Eluting Stents; Female; Gastrointestinal Neoplasms; Humans; Male; Paclitaxel | 2013 |
Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Coated Materials, Biocompatible; Female; Follow-Up Studies; Humans; Incidence; Male; Metals; Middle Aged; Paclitaxel; Pilot Projects; Postoperative Complications; Prospective Studies; Prosthesis Design; Prosthesis Implantation; Stents; Survival Rate; Treatment Outcome | 2007 |
17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
Topics: Cholestasis; Doxorubicin; Drug Resistance; Estradiol; Estriol; Etoposide; Humans; Leukemia, Myeloid; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Vinblastine | 1993 |
MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
Topics: Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Carrier Proteins; Cholestasis; Chromatography, High Pressure Liquid; Cyclosporine; Daunorubicin; Estradiol; Male; Paclitaxel; Rats; Rats, Sprague-Dawley | 1996 |
Adenosine triphosphate-dependent transport of estradiol-17beta(beta-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Baculoviridae; Biological Transport, Active; Cell Line; Cell Membrane; Cholestasis; Doxorubicin; Estradiol; Gene Expression; Kinetics; Liposomes; Male; Paclitaxel; Rats; Rats, Sprague-Dawley; Spodoptera; Transfection | 1998 |